Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells - Michaelis, Martin; Rothweiler, F.; Barth, S.; Cinatl, J.; Rikxoort, M. van; Löschmann, N.; Voges, Y.; Breitling, R.; Deimling, Andreas von; Rödel, F.; Weber, Kristoffer; Fehse, Boris; et al. (Cell death & disease, 2011)